Institute for Applied Cancer Science

Meet the Team

Our staff of approximately 60 scientists, most recruited from leading biotechnology and pharmaceutical companies, drive programs in metabolism, epigenetics, and signaling from target identification through preclinical testing. Collectively, IACS team members have several hundred years of industry experience, as well as proven track records of effectively translating targets into clinically significant treatments that are in late-stage clinical trials, in addition to three FDA-approved agents.